Industry News

News Powered By:

- a collaborative partner.


 


Physicians to pharmas: provide patient services or face irrelevance


CenterWatch News Online Headlines : October 17, 2014 9:49 am : Centerwatch

Physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services, according to the ePharma Physician 2014 study from Manhattan Research, part of Burlington, Mass.-based Decision Resources Group.



Study: strong consumer interest in storing, sharing health data


CenterWatch News Online Headlines : October 17, 2014 9:47 am : Centerwatch

As Apple, Samsung and Google field health and fitness data aggregators, 30% of online consumers would be interested in using such a service, and more than one-third would consider doing so if it saved them money.



Cardiorentis, Roche collaborate on Ularitide


CenterWatch News Online Headlines : October 17, 2014 7:49 am : Centerwatch

Cardiorentis, a Switzerland-based, privately held biopharmaceutical company, is collaborating with Roche to establish the therapeutic efficacy and safety of Ularitide, the company’s investigational drug for acute heart failure (AHF). Cardiorentis will incorporate Roche’s advanced in vitro diagnostic tests into its TRUE-AHF phase III study to characterize the pharmacological properties of Ularitide, evaluate its benefit-risk profile and the appropriate clinical application in patients.



Sanofi Pasteur, Immune Design collaborate on herpes simplex virus therapy


CenterWatch News Online Headlines : October 17, 2014 7:48 am : Centerwatch

Immune Design, a California-based clinical-stage immunotherapy company, has entered into a broad collaboration for the development of a herpes simplex virus (HSV) immune therapy with Sanofi Pasteur, the vaccines division of Sanofi.



AstraZeneca, University of Cambridge strengthen partnership


CenterWatch News Online Headlines : October 17, 2014 7:46 am : Centerwatch

AstraZeneca, together with its global biologics R&D arm MedImmune, has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The latest collaborations reinforce AZ’s commitment to creating a permeable research infrastructure in Cambridge following its decision to locate one of its three global R&D centers and its global headquarters in the city, which has been home to MedImmune’s biologics research laboratories for 25 years.


« Page 1, 2, 3450 »